Influenza: options to improve pandemic preparation.
Science and society have been struggling to find a way to protect humankind from recurring epidemics and pandemics of influenza. Here, we review the options available in the short term and also briefly address the solutions that research may make available in the long term.
Novartis Vaccines and Diagnostics, Siena, Italy. rino.rappuoli@novartis.com
Rino
R
Rappuoli
Philip R
PR
Dormitzer
D056738:Cross Protection; D014943:Global Health; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology / Q000472:pathogenicity; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000600:supply & distribution; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control* / Q000635:transmission / Q000821:virology; D032541:Mass Vaccination; D058873:Pandemics / Q000517:prevention & control*; D019444:Vaccines, DNA
D007252:Influenza Vaccines; D019444:Vaccines, DNA